Free shipping on all orders over $ 500

GNF179

Cat. No. M4892

All AbMole products are for research use only, cannot be used for human consumption.

GNF179 Structure

Price and Availability

For this product's availability, delivery time and price, please email [email protected] directly or click the "Inquiry Now" button below.


Quality Control & Documentation
Biological Activity

GNF179 is an optimized 8,8-dimethyl IP analog that exhibited the potency(4.8 nM against the multidrug resistant strain W2) in vitro metabolic stability and in vivo oral bioavailability. IC50 value: 4.8 nM. Target: Anti-parasitic agent GNF179 exhibits a low clearance (CL=22 ml/min/kg, ~25% of hepatic blood flow in mice), a large volume of distribution (steady-state volume of distribution, Vss=11.8 l/kg), a moderate residence time (MRT=9 hours) and suitable terminal half-life (t1/2=8.9 hours). GNF179 reduced Plasmodium berghei parasitemia levels by 99.7% with a single 100 mg/kg oral dose, and prolonged mouse survival by an average of 19 days. GNF179 was able to protect against an infectious P. berghei sporozoite challenge with a single oral dose at 15 mg/kg while NITD609 was not.

Protocol (for reference only)
Cell Experiment
Cell lines P. falciparum Asexual Blood Stage
Preparation method The half maximal inhibitory concentration (IC50) of GNF179 was determined to be 9.0 nM using a 72 hr SYBR® Green I drug sensitivity assay.
Concentrations 40 nM
Incubation time 72 h
Animal Experiment
Animal models
Formulation
Dosages
Administration
Chemical Information
Molecular Weight 427.9
Formula C22H23ClFN5O
CAS Number 1261114-01-5
Form Solid
Solubility (25°C) 10 mM in DMSO
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
References

[1] Magistrado PA, et al. ACS Infect Dis. Plasmodium falciparum Cyclic Amine Resistance Locus (PfCARL), a Resistance Mechanism for Two Distinct Compound Classes.

[2] Lim MY, et al. Nat Microbiol. UDP-galactose and acetyl-CoA transporters as Plasmodium multidrug resistance genes.

Related Parasite Products
Nanaomycin A

Nanaomycin A is the first selective DNMT3B inhibitor with an IC50 of 500 nM. Nanaomycin A, a quinone antibiotics, reactivates silenced tumor suppressor genes in human cancer cells. Nanaomycin A inhibits in vitro growth of the human malaria parasite Plasmodium falciparum with an IC80 value of 33.1 nM.

Ivermectin B1a

Ivermectin B1a is a main component of Ivermectin. Ivermectin (MK-933) is a broad-spectrum anti-parasite agent.

Asparagusic acid

Asparagusic acid is a sulfur-containing flavor component produced by Asparagus officinalis Linn., with anti-parasitic effect. Asparagusic acid is also a plant growth inhibitor.

ML251 

ML251, a potent nanomolar T.

AN3661 

AN3661, a potent antimalarial lead compound, targets a Plasmodium falciparum cleavage and polyadenylation specificity factor homologue subunit 3 (PfCPSF3).

  Catalog
Abmole Inhibitor Catalog




Keywords: GNF179 supplier, Parasite, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.